November 18, 2019
A key health ministry advisory committee will review a batch of new drugs and indications on November 29 for their possible approval, including Eisai’s insomnia medicine lemborexant, but there will be no discussion for Ono Pharmaceutical’s cancer cachexia treatment anamorelin,...read more